Global Psychedelic Therapeutics Market Analysis and Forecast to 2030
Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis

Psychedelicsubstances have been demonstrated to interact with a variety ofneurotransmitter pathways, including those involving serotonin, acetylcholine,norepinephrine, and dopamine. Currently, several stakeholders in thepharmaceutical industry are actively engaged in the efforts to develop leadsbased on natural and synthetic derivatives of psychedelic substances. Further,experts believe that psychedelics, at appropriate doses, can be used to addresssome of the serious psychological implications associated with the COVID-19 pandemic.

RootsAnalysis has announced the addition of “Global Psychedelic Therapeutics Market,2020-2030”report to its list of offerings.

Theover USD 6.5 billion (by 2030) financial opportunity within the PsychedelicTherapeutics market has been analyzed across the following segments:

TargetDisease Indication

·       Anxiety and Depression

·       Trauma

·       Pain Disorder

·       Sleep related Disorder

Originof Psychedelic Substance

·       Natural

·       Synthetic

Typeof Psychedelic Substance

·       Gamma-hydroxybutyrate

·       Ketamine

·       MDMA

·       Psilocybin

Routeof Administration

·       Oral

·       Intranasal

·       Sublingual

KeyGeographies

·       North America

·       Europe

·       Asia-Pacific

TheGlobal Psychedelic Therapeutics Market, 2020-2030 report features the followingcompanies, which we identified to be key players in this domain:

·       Celon Pharma

·       iX Biopharma

·       MAPS Public Benefit

·       MindMed

·       Janssen Pharmaceuticals

·       Jazz Pharmaceutical

 

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape:Psychedelic Therapeutics

5. Company Profiles

6. Clinical Trial Analysis

7. Clinical Trial SiteAnalysis

9. Key Opinion Leader (KOL)Analysis

8. Academic Grants Analysis

10. Partnerships andCollaborations

11. Mergers and Acquisitions

12.  Market Forecast and Opportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: TabulatedData

16. Appendix 2: List ofCompanies and Organizations

Formore information, please click on the following link:

https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com